Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Hologic, Inc shares valued at $300,760 were purchased by Madaus Martin D on May 07 ’25. At $55.24 per share, Madaus Martin D acquired 5,445 shares. The insider’s holdings grew to 5,445 shares worth approximately $0.36 million following the completion of this transaction.
Also, Mitchell Essex D sold 24,856 shares, netting a total of over 1,897,482 in proceeds. Following the sale of shares at $76.34 each, the insider now holds 27,957 shares.
Before that, Mitchell Essex D had added 24,856 shares to its account. In a trade valued at $1,897,484, the Officer bought Hologic, Inc shares for $76.34 each.
As published in a research note from RBC Capital Mkts on August 06, 2025, Hologic, Inc [HOLX] has been rated up from a Sector perform to an Outperform and the price target has been revised to $87. Analysts at Citigroup upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early July. As of May 27, 2025, Needham has reiterated its “Hold” rating for HOLX. Earlier on March 03, 2025, Argus downgraded its rating. Their new recommendation was “a Hold” for HOLX stock which previously was a “a Buy”.
Analyzing HOLX Stock Performance
On last trading session, Hologic, Inc [NASDAQ: HOLX] plunged -1.37% to $66.89. The stock’s lowest price that day was $66.86, but it reached a high of $69.07 in the same session. During the last five days, there has been a surge of approximately 2.94%. Over the course of the year, Hologic, Inc shares have dropped approximately -20.03%.
Is Hologic, Inc subject to short interest?
Stocks of Hologic, Inc saw a sharp rise in short interest on 2025-07-15 jumping by 0.11 million shares to 5.15 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 5.03 million shares. A jump of 2.2% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.16 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.16.
Which companies own the most shares of Hologic, Inc (HOLX)?
In terms of Hologic, Inc share price expectations, FactSet research, analysts set an average price target of 70 in the next 12 months, up nearly 3.21% from the previous closing price of $67.82. Analysts anticipate Hologic, Inc stock to reach 75 by 2025, with the lowest price target being 65. In spite of this, 10 analysts ranked Hologic, Inc stock as Buy at the end of 2025. On February 06, 2025, Leerink Partners assigned a price target of “a Market perform” to the stock and downgraded coverage with a $75.
